View allAllogeneic Cell SourcingCell Collection NetworkCell Therapy Supply ChainClinical Trials SupportIndustry StandardizationOutcomes ReportingSales Sheets
Sort by dateSort by name
DescendingAscending
Webinar

How Starting Material Quality Impacts the Manufacturing and Success of Next-Generation Therapies

Allogeneic Cell Sourcing, Cell Collection Network

This on-demand webinar helps answer the question, “What constitutes quality allogeneic cell therapy starting material and how you can ensure it?” The webinar explores specific risks and practical downstream repercussions of insufficient and variable starting material quality. Our expert panelists discuss how to help ensure both high-quality and consistent cellular starting material by building efficiencies…

Webinar

Critical Components for Developing & Managing Expansive, High-Performing Collection Networks

Cell Collection Network

A high-performing collection center network is essential to providing and delivering quality starting material for emerging cell and gene therapies. Learn about effective practices for building and maintaining collection networks in our on-demand webinar, Critical Components for Developing & Managing Expansive, High-Performing Collection Networks. Amy Hines, BSN, RN, director, Collection Network Management, Be The Match BioTherapies®,…

Webinar

Strategies to Relieve the Burden on Apheresis & Collection Centers

Cell Collection Network, Industry Standardization

As cell and gene therapies continue to progress at a rapid pace, apheresis and collection centers face the challenges of keeping up with demand, while maintaining high-quality levels. View this on-demand webinar for an in-depth discussion of standardization strategies that can bring efficiencies to the apheresis and collection infrastructure. Also included is a Q&A session…

Webinar

From Clinic to Commercial Reality: Leveraging Transplant Experience to Overcome Cell Therapy Supply Chain Hurdles

Cell Therapy Supply Chain

View this on-demand presentation of From Clinic to Commercial Reality by our Director of Cell and Gene Therapy Operations, Jamie Margolis, PhD, and our Vice President of Business Development and Strategic Partnerships, Mark Flower, to learn more about how NMDP BioTherapies (formerly Be The Match BioTherapies) is going beyond hematopoietic cell transplant and leveraging 30+…